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Abstract 
Pain has the capacity to interfere with daily tasks. Although task interference by pain is largely 
unintentional, it can be controlled to a certain extent. Such top-down control over pain has been thought to 
be reduced in fibromyalgia patients. In this study, we investigated task interference and distraction efficacy 
in fibromyalgia patients (FM) and a matched healthy control group. Forty-nine fibromyalgia patients and 
49 heathy volunteers performed as quickly as possible (a) a visual localization task in the presence of non-
painful vibrating or painful electric somatic stimuli, and (b) a somatosensory localization task (using non-
painful or painful stimuli). Participants reported on their experience of the somatic stimuli on some of the 
trials during both localisation tasks. Results indicated that pain interferes with performance of the visual 
task, in both FM patients and healthy individuals. Furthermore, participants experienced the pain stimulus 
as less intense when directing attention away from the pain than when focusing on the pain. Overall, task 
performance of FM patients was slower compared to the task performance in the healthy control group. In 
contrast to our hypotheses, FM patients and healthy volunteers did not differ in the magnitude of the 
interference effect and distraction-efficacy. In conclusion, current study provides support for contemporary 
theories claiming that attention modulates the experience of pain and vice versa. However, no evidence was 
found for an altered attentional processing of pain in fibromyalgia patients. Furthermore, results indicate 
that task interference and distraction-efficacy are not just two sides of the same coin. 
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Introduction 
A key feature of pain is its ability to demand attention [15,57]. In acute pain, this feature is 
adaptive as it urges a person to escape from bodily threat [15]. In the long-term, however, this 
ability may become maladaptive as pain interferes with the capability to fulfil daily tasks and goal 
pursuit [16,18,49]. The interference of pain with task performance has been documented in healthy 
individuals experiencing acute pain (e.g., [3,6,9,35]) as well as in those with chronic pain (e.g., 
[14,37]). Whereas the capture of attention by pain may be largely unintentional, it can be 
controlled to some extent. Indeed, several studies have shown that directing attention away from 
pain by engaging in a task unrelated to pain (i.e., attentional distraction) reduces acute pain and 
related distress [5,7,17,23,24,33].  
The answers to the questions “How and when does pain interfere with ongoing tasks” (task 
interference), and “how and when does directing attention away from pain diminishes pain 
(distraction efficacy)” are often grounded in similar theoretical frameworks (e.g., [10,15,29,]). 
Nevertheless, only few studies have simultaneously investigated task interference and distraction 
efficacy (see [42] for an exception). Furthermore, these frameworks often (implicitly or explicitly) 
assume that the magnitude of both phenomena is altered in people with chronic pain [19,29,37]. 
Research comparing task interference and/or distraction efficacy between healthy participants and 
chronic pain patients is however largely lacking. The need for further research comparing both 
phenomena has been emphasised in a recent meta-analysis summarizing available work on the 
effects of distraction in chronic pain patients [54]. In contrast to research in healthy volunteers, 
available research in chronic pain patients suggests that directing attention away from pain does 
not reduce pain and distress. Notwithstanding, more research is needed because the available 
evidence consisted largely of studies that did not include healthy control groups, used small 
samples and suffered from methodological shortcomings (e.g., no control for alternative coping 
strategies in the control condition). If proven, distraction inefficacy in chronic pain patients may 
point at the presence of (a) heightened levels of vigilance for pain and/ or somatic sensations in 
general [11,12,57] or (b) problems of executive functioning in chronic pain patients [4,37]. Both 
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explanations have been put forward to explain the failure of distraction in chronic pain patients 
[25,28,56].  
In the current study, we investigated, both, task interference and distraction efficacy in a 
sample of fibromyalgia (FM) patients and a matched healthy control group. FM patients were 
selected because previous research suggests that they are prone to impairments of attention and 
show reduced levels of executive functions (e.g., [47]). We hypothesized that (a) pain would 
interfere with task performance in healthy participants and FM patients, albeit to a larger extent in 
FM patients; (b) directing attention away from pain would reduce the experience of pain in healthy 
volunteers, but not or to a lesser extent in FM patients, and (c) pain intensity would affect the 
magnitude of task interference and distraction efficacy. For exploratory purposes, we also 
examined the relationship between distraction efficacy, task interference, and their relationship 
with other constructs presumed to be play a role in both phenomena.   
 
Method 
Participants 
The study sample (N = 98) consisted of FM patients (N = 49) and healthy volunteers (N = 
49) aged between 18 and 65 years, who were recruited for the ASEF-I-project. Within the ASEF-I-
project, a group of FM patients and a matched group of healthy participants were recruited to 
investigate attention and self-regulatory processes. The full project protocol, detailing the study 
design and flow can be retrieved via following link: http://hdl.handle.net/1854/LU-5686902. 
Recruitment of participants took place between January and March 2014. Participants were only 
included if they (1) had sufficient knowledge of the Dutch language; (2) did not suffer from a 
neurological condition; (3) could use both index fingers; (4) did not report abnormal sensations in 
the arms; (5) had a normal or corrected-to-normal (e.g., by glasses) eyesight; (6) were not 
pregnant; and (7) did not have a pacemaker. In addition, FM patients were only included if they 
had received a FM diagnosis and fulfilled the American College of Rheumatology (ACR)-2010-
criteria [58], and healthy participants if they did not report a current pain problem. FM patients and 
healthy participants were matched at group level for age, sex and educational level. FM patients 
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were recruited in the Multidisciplinary Pain Clinic of Ghent University Hospital. They were 
informed about the study via a poster in the waiting room of the hospital. Patients who were 
interested in taking part left their contact details. The healthy control group was recruited via 
advertisements in a local newspaper, flyers and the university website. Healthy participants who 
fulfilled the eligibility criteria were contacted by telephone and informed about the study. For 
participants who agreed to participate, an appointment was scheduled for a laboratory session. A 
flow chart indicating the exact number and reasons of non-participation of participants can be 
found in the full study protocol of the ASEF-I-project. The study was approved by the medical 
ethics committee of the University Hospital of Ghent (registration number: 2013/1016). 
 
Apparatus and somatosensory stimuli 
 Somatosensory stimuli consisted of painful and non-painful stimuli. Non-painful stimuli 
were tactile stimuli (frequency = 200 Hz; duration = 300 ms; intensity = 0.07 Watt) and presented 
with two resonant-type tactors (C-2 TACTOR, Engineering Acoustics, Inc., Florida) consisting of 
a box of 3.05 cm diameter and 0.79 cm height, with a skin contactor of 0.76 cm diameter. Painful 
stimuli were electrocutaneous stimuli (bipolar; 50 Hz; 300 ms; instantaneous rise and fall time) 
delivered by a constant current stimulator (DS5, Digitimer Ltd, Hertfordshire, United Kingdom). 
All somatosensory stimuli were delivered in the region of the medial cutaneous nerve of the left 
forearm (close to wrist or close to the elbow; see figure 1)  
 
Self-report measures 
Fibromyalgia symptoms were assessed using the widespread pain index (WPI) score, 
which represents a number of whole-body pain areas (max score = 19), and the symptom severity 
(SS) score that quantifies symptom severity on a 0-12 scale by scoring problems with fatigue, 
cognitive dysfunction and unrefreshed sleep over the past week. In line with the 2010 ACR criteria 
[58], participants satisfied the fibromyalgia criteria if they had a (1) WPI score greater than or 
equal to seven and a SS score greater than or equal to five or (2) a WPI score ranging from three to 
six and a SS score greater than or equal to nine.  
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Pain severity was assessed with the pain severity subscale of the Multidimensional Pain 
Inventory (MPI; [26,31]). The MPI (Part 1) consists of five subscales assessing the impact of pain 
on a 7-point Likert scale ranging from 0 to 6. Pain severity was assessed with two items (i.e., “Rate 
the level of your pain at the present moment” and “On average, how severe has your pain been 
during the last week?”). In line with previous studies, the third item (“How much suffering do you 
experience because of your pain?”) of the pain severity subscale was not taken into account given 
that its content relates to suffering rather than pain severity (see also [40,53]). The MPI has shown 
good reliability and validity [43]. In the present study, Cronbach’s alpha of the MPI severity 
subscale was .84. 
Pain-related disability was measured with the Pain Disability Index (PDI; [41]) which 
assesses the level of restriction in participation in seven life domains (e.g., family) on a scale 
ranging from 0 (no disability) to 10 (total disability). Participants were asked to evaluate the 
overall impact of pain (not just when pain is at its worst) on each of the seven life domains, on a 
scale from 0 to 70. Cronbach’s alpha of the PDI was .82.  
Depressive mood, anxiety and stress during the past week were assessed using the 
Depression Anxiety Stress Scales (DASS; [32]). Each sub-scale contains 14 items (e.g. “I found it 
hard to wind down”, “I felt I was pretty worthless”), which were rated on a 4-point Likert scale 
ranging from 0 (“did not apply to me at all”) to 3 (“applied to me very much, or most of the time”).  
In the present study, Cronbach’s alpha for the depression, anxiety and stress subscales were 
respectively .96, .91 and .95.  
Pain catastrophizing was assessed using the Pain Catastrophizing Scale (PCS; [46]). This 
scale contains 13 items that measure catastrophic thoughts about pain in both clinical and non-
clinical samples. To answer these items participants are required to think about past painful 
experiences and indicate on a 5-point scale (ranging from 0 [“not at all”] to 4 [“always”]) the 
degree to which they experienced each of the 13 thoughts or feelings (i.e. “When I’m in pain it’s 
terrible and I think it’s never going to get any better”). Research has shown that the PCS is valid 
and reliable [48]. In the present study Cronbach’s alpha of the total PCS score was .95. 
 5
Vigilance for bodily symptoms was measured using the Body Vigilance Scale (BVS; [44]). 
The BVS is a 4-item questionnaire measuring vigilance for bodily symptoms on a 11-point 
numerical rating scale (e.g., “I am very sensitive to changes in my internal body sensations”). The 
last item is an average of the awareness scores of 15 non-specific body symptoms (e.g., “rate how 
much attention you pay to each of the following sensations [e.g., heart palpitations, tingling, 
nausea]”). Cronbach's alpha of the four BVS-items in this study was .73. 
 
Experimental task 
 The experimental task was programmed and presented using the INQUISIT Millisecond 
software package (Inquisit 3; Seattle, WA: Millisecond Software) on a Dell computer (Intel Core2 
Duo P8600, 4096MB) with a 60-Hz, 17-inch colour CRT monitor. The experiment consisted of 
localizing either the somatosensory stimuli (non-painful, low painful, moderately painful) during a 
somatosensory localisation task (somatosensory focus task), or the visual stimuli during a visual 
localisation task (visual focus task = distraction task). Somatosensory and visual stimuli were 
simultaneously presented during each trial. In 50% of the trials, participants were instructed to 
localize as quickly as possible whether the visual stimulus (i.e. 1cm x 1cm black square) was 
presented to the left or right side of the screen (visual focus trials). On the remaining trials, 
participants were instructed to localize as quickly as possible whether the somatosensory stimulus 
was presented to the left (close to the elbow) or right (close to the wrist) location on the left arm 
(somatosensory focus trials). Each trial started with a visual cue consisting of a full coloured circle 
(either blue or yellow; 1000 ms duration) in the centre of the screen that indicated which modality 
was relevant and needed to be attended to. Somatosensory and visual stimuli were presented the 
same number of times at the left and right location. A total of 256 trials were presented. In 192 
(75%) trials, the somatosensory stimulus consisted of non-painful tactile stimuli. In the other 64 
(25%) trials, the somatosensory stimulus consisted of painful electrocutaneous stimuli (32 trials 
with low intense pain and 32 trials with moderately intense pain). Furthermore, 25% of the non-
painful trials (i.e., 48 trials) and 75% of the painful trials (i.e., 48 trials) were followed by two 
visual analogue scales (“How intense was the last somatosensory stimulus” [0 = totally not intense; 
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10 = very intense]; “How unpleasant was the last somatosensory stimulus” [0 = totally not 
unpleasant; 10 = very unpleasant]) that probed the intensity and the unpleasantness of the 
experienced pain. Trials with vibrotactile stimuli were implemented for several reasons. First, 
somatosensory trials were included as a control category to investigate the magnitude of task 
interference by pain. Second, the inclusion of somatosensory trials reduced the overall percentage 
of trials that were followed by a pain rating. Hence, the possibility that participants attended to the 
somatosensory stimuli during visual modality trials because they expected to rate the 
somatosensory stimuli was kept low (see also [51]). This resulted in six trial types: (1) non-painful 
somatosensory focus trials, (2) low painful somatosensory focus trials, (3) moderately painful 
somatosensory focus trials, (4) non-painful visual focus trials, (5) low painful visual focus trials, 
and (6) moderately painful visual focus trials. Each trial type was presented ‘equi-probably’ and 
randomly at the left and right location. Participants indicated the location of the stimuli using the 
right hand on the keyboard (4 = left; 6 = right) (see Figure 1 for a schematic presentation of the 
study set-up).  
 
Procedure 
 Prior to the experimental session (i.e., before scheduling the laboratory session and providing 
general study information), all participants were asked to complete a number of questionnaires at 
home (including the MPI, DASS, PDI, BVS, PCS, demographic information), either online (via 
LimeSurvey) or on paper. Upon arrival, all participants received additional information about the 
study and signed an informed consent form. Thereafter, all participants performed several 
experimental tasks as part of the ASEF-I project. The experimental task described in the current 
study was the first (after ACR-criteria assessment and a 10-minute resting period during which 
heart-rate was monitored) that people performed. Before starting the experimental task, 
participants filled out how intense the pain was (VAS ranging from 0 = no pain to 100 = worst 
imaginable pain) and how much fatigue (VAS ranging from 0 = not at all to 100 = very much) they 
experienced at that moment. Furthermore, participants received the following information “During 
this task non-painful and painful stimuli will be administered. The intensity of the stimuli may 
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differ more or less from each other.” After receiving this information, the left arm of the 
participants was scrubbed and two lubricated Technomed Europe surface electrodes (Maastricht, 
The Netherlands; 1 cm diameter) and two resonant-type tactors (C-2 TACTOR, Engineering 
Acoustics, Inc., Florida) were attached at two locations of the left forearm (close to the wrist or the 
elbow) situated in the medial cutaneous nerve area. Next, the intensity of the electrocutaneous 
stimuli was individually determined for each participant by administering electrocutaneous stimuli 
of increasing intensity at both locations of the arm (starting with 0.5 mA) and increasing with steps 
of 0.5mA. During the calibration phase, participants were instructed to pay close attention to the 
pain stimulus when judging its intensity. The intensity of the electroctaneous stimulus increased 
until participants reported that the pain stimulus they received was of moderate pain (on a scale 
ranging from “no pain”, "little pain", "moderate pain", "intense pain", "enormous pain" and 
"unbearable pain"). This moderately intense pain stimulus was then used during the experimental 
task. A so-called ‘low intense pain’ stimulus was derived from the moderately intense pain 
stimulus using the formula provided by Arntz and colleagues [2]. This procedure resulted in an 
overall mean objective stimulus intensity of 3.79 mA (SD = 2.02) and 3.56 mA (SD = 1.97) for the 
left and right moderately intense pain stimulus, respectively and an overall mean objective 
stimulus intensity of 3.38 mA (SD = 1.82) and 3.18 mA (SD = 1.78) for the left and right low 
intense pain stimulus. The objective stimulus intensity did not differ significantly between 
locations (All F(1, 96) < 2.35, ns), but did differ between groups (moderately intense pain stimulus: 
F(1, 96) < 28.25,  p <.001; low intense pain stimulus: F(1, 96) < 28.03,  p <.001), indicating that the 
objective intensity of the pain stimuli was lower for FM patients (moderately intense pain stimulus: 
M = 2.79 mA, SD = 1.35; low intense pain stimulus: M = 2.49 mA, SD = 1.22) than for healthy 
controls (moderately intense pain stimulus: M = 4.56 mA, SD = 1.89; low intense pain stimulus: M 
= 4.07 mA, SD = 1.71). 
 
- INSERT FIGURE 1 ABOUT HERE - 
 
Data analyses 
 8
Statistical analyses were performed with SPSS statistical software, version 24.0 for Windows 
(SPSS Inc., Chicago, IL). Analyses investigating task interference by pain in healthy participants 
and FM patients were performed on the response latencies of distraction (i.e. performance of the 
visual task) trials only, using a repeated measures analysis of variance (ANOVA) with 
Somatosensory Stimulus (non-painful vs low painful vs moderately painful) and Group (healthy 
controls vs FM patients) as a between-group factor. Contrast analyses were used to investigate the 
effect of pain intensity upon the magnitude of task interference. Analyses investigating distraction 
efficacy in healthy participants and FM patients were performed on pain intensity and 
unpleasantness ratings of the painful stimuli only. Pain intensity and unpleasantness ratings of the 
vibrotactile stimuli were not analyzed (see above). For each dependent variable (pain intensity and 
unpleasantness), a repeated measures ANOVA with Pain Stimulus (low painful vs moderately 
painful) and Modality Relevance (somatosensory relevant/ visual relevant) as within-subject 
factors and Group (healthy controls vs FM patients) as between-group factor was conducted. When 
appropriate, contrast analyses were used.   
For all analyses, Greenhouse–Geisser corrections (with adjusted degrees of freedom) were 
performed whenever the sphericity assumption was violated (Mauchly test of sphericity was p < 
.05). Furthermore, the cut-off for statistical significance was set at p < .05, and effect sizes were 
reported using the partial eta squared index (ηp2) and when appropriate Cohens’ d (see also 
[8,27,39]). 
 
Results 
Descriptives 
Mean age of participants was 45.30 years (SD = 10.74; range 22- 65 years), and 81 of them 
were female (82.7%). The majority of the participants was married or living together (55.1%). 
Almost half of the sample graduated from high school or university (45.9%). For FM patients, the 
mean pain duration was 186.36 months (SD = 115.14). The two groups did not differ in terms of 
age, sex distribution or educational level (see Table 2 for an overview). FM patients reported a 
mean pain severity level (MPI) of 3.62 (SD = 1.07) and mean level of restrictions in participation 
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(PDI) of 41.80 (SD = 10.39). All FM patients fulfilled the 2010 ACR criteria [58] with a mean 
WPI score of 11.84 (SD = 3.33) and mean SS score of 8.96 (SD = 1.63). Most commonly reported 
pain locations were neck (95.9%), shoulder (left side: 89.8%, right side: 91.8%) and back (upper 
back: 91.8%, lower back: 93.9%). 
 
- INSERT TABLE 1 ABOUT HERE - 
 
Task interference by pain 
Before performing RT analyses, errors (2.7%) and outliers were removed. Data with response 
latencies shorter than 200ms (anticipations) or three SDs above the individual mean RT of correct 
responses for each trial type were considered outliers and excluded from further analyses (1.6%). 
Next, a 3 (Somatosensory Stimulus: non-painful vs low painful vs moderately painful) x 2 (Group: 
FM patients vs healthy controls) repeated measures ANOVA was performed. Results showed a 
main effect for Somatosensory Stimulus (F(1.78, 170.83) = 53.50, p < .001, ηp2 = 0.358) and Group (F(1, 
96) = 8.07, p < .01, ηp2 = 0.078). There was no interaction effect (F(1.78, 170.83) = 1.60, ns; see Figure 
2). Planned contrasts showed that participants were significantly slower in performing the visual 
tasks when receiving moderately (M = 735.89, SD = 260.24) compared to low intense painful 
stimuli (M = 712.36, SD = 234.04; F(1, 96) = 5.43, p < .05, ηp2 = 0.054, drm = 0.09, CI = 0.01: 0.17). 
Participants were also significantly slower to perform the visual tasks when receiving low intense 
pain stimuli (M = 712.36, SD = 234.04) compared to non-painful stimuli (M = 620.53, SD = 
176.35; F(1,96) = 65.08, p < .001, ηp2 = 0.404, drm = 0.39, CI = 0.29: 0.49). For follow-up 
correlations (section correlational analyses), an overall pain interference index was calculated by 
subtracting the average RT on non-painful trials from the mean of the average RTs of low and 
moderately painful trials. A positive index indicated a delayed response due to the presence of 
pain, whereas a negative index indicated a speeded response due to the presence of pain. 
 
- INSERT FIGURE 2 ABOUT HERE - 
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Distraction efficacy 
Analyses concerning distraction efficacy were performed on the ratings of all correctly 
answered pain trials (i.e., 94.1% of all possible pain trial ratings). A 2 (Modality Relevance: 
somatosensory relevance vs visual relevance) x 2 (Pain Stimulus: low painful vs moderately 
painful) x 2 (Group: FM patients vs healthy controls) repeated measures ANOVA was performed 
for pain intensity and unpleasantness. For pain intensity, a main effect was found for Pain Stimulus 
(F(1, 96) = 66.46, p < .001, ηp2 = 0.409, drm = 0.13, CI = 0.10: 0.16) indicating that participants 
experienced the moderately intense pain stimulus (M = 42.79, SD= 23.73) as more painful than the 
low intense pain stimulus (M = 39.66, SD = 22.64). Also a main effect was found for Modality 
Relevance (F(1, 96)=31.31, p < .001, ηp2 = .25, drm = 0.08, CI = 0.05: 0.11), in that participants 
experienced less pain during visual modality trials (M = 40.29, SD = 23.00) than during 
somatosensory modality trials (M = 42.15, SD = 23.33). In contrast to our expectation, there was 
no interaction-effect between Group and Modality Relevance (F(1, 96) < 1, ns). No other main 
effects or interaction effects were significant (all Fs > 1.79). Results for pain unpleasantness were 
similar such that there was a main effect of Pain Stimulus (F(1,96) = 87.98, p <.001, ηp2 = 0.478, drm 
= 0.16, CI = 0.12: 0.19), indicating that participants experienced the moderately intense pain 
stimulus (M = 41.63, SD = 23.55) as more unpleasant than the low intense pain stimulus (M = 
37.92, SD = 22.53). In addition, we found a main effect for Modality Relevance (F(1, 96) = 30.91, p 
< .001, ηp2 = 0.244, drm = 0.09, CI = 0.06: 0.12), indicating that pain was perceived as less 
unpleasant during visual modality trials (M = 38.71, SD = 22.71) than during somatosensory 
modality trials (M = 40.84, SD = 23.37). Again, in contrast to our expectation, no interaction-effect 
was found between Group and Modality Relevance (F(1,96) < 1, ns). No other main effects or 
interaction effects were significant (all Fs > 1). For follow-up correlations (section correlational 
analyses), a distraction-efficacy index was calculated by subtracting the mean of the average 
ratings on low and moderately painful visual focus trials from that of the low and moderately 
painful somatosensory focus trials for pain intensity and unpleasantness ratings, respectively. 
Given that the distraction-efficacy indices for pain intensity and unpleasantness were highly 
correlated, an overall pain distraction-efficacy was calculated by averaging both indexes. 
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- INSERT TABLE 2 ABOUT HERE - 
 
Correlational analyses 
In a final exploratory step, we investigated whether task interference by pain and distraction 
efficacy were related. In addition, we explored their relationship with individual difference 
variables (e.g., anxiety, pain intensity). For variables measured in both groups, i.e., FM patients 
and healthy controls, partial correlations were performed to control for the impact of Group. For 
the variables that were only measured in the FM patient group, Pearson correlations were 
performed. Correlation analyses showed that the magnitude of distraction efficacy and task 
interference by pain did not correlate (r = .06, ns). Distraction efficacy was, however, negatively 
related to  anxiety (DASS-A, r = -.18, p = .09), pain catastrophizing (PCS, r =-.18, p = .08), pain 
severity (MPI-ps, r =-.26, p = .07), and fatigue at the moment of testing (fatigue, r =-.25, p = .01), 
suggesting that distraction is most effective in people who are less anxious, are low catastrophizing 
about pain, report less severe pain or are less fatigued, respectively. In contrast, task interference 
by pain was not related to any of the investigated individual differences variables (see Table 2). 
 
Discussion 
This study investigated task interference and distraction efficacy in FM patients, and in a 
matched healthy control group. The results can be readily summarised. First, we found that pain 
interferes with task performance in FM patients as well as healthy individuals. Second, participants 
experienced the pain stimulus as less intense when directing attention away from the pain stimulus 
(i.e., when performing a visual task) than when focusing on the pain. In contrast to our hypothesis, 
no difference was found in the magnitude of the interference effect and distraction-efficacy 
between FM patients and healthy controls. Finally, our findings indicate that the indices of task 
interference and distraction-efficacy are not related to each other, suggesting that they are not two 
sides of the same coin.  
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In line with previous research, the current findings show that pain interferes with task 
performance in both healthy participants [35,36] and chronic pain patients (e.g., [14]). Indeed, 
participants’ performance on a visual detection task was significantly slowed when receiving a 
painful in comparison to a non-painful tactile stimulus. Furthermore, to our knowledge the current 
study is one of the first to show that the interference effect increases with the intensity of the pain 
stimulus. This finding is in line with earlier theories that state that salient stimuli - i.e., stimuli 
which are more intense, more threatening, more novel or less predictable - are more likely to 
capture attention [15,29]. 
 Furthermore, the findings of the current study indicate that distraction from pain may 
result in reduced experience of a low to moderately intense pain stimulus. Yet, the efficacy of the 
distraction task was not dependent upon the intensity of the pain stimulus. This finding appears to 
be in contrast with research suggesting that distraction is more effective for less intense pain 
[33,54]. It is, however, possible that the difference in the intensity of the pain stimuli (low vs 
moderately painful) was too small to show the impact of pain intensity upon distraction efficacy. It 
may also be that there is no linear relationship between pain intensity and distraction efficacy, but 
that distraction is successful until pain intensity exceeds a certain level of intensity [52]. Contrary 
to our expectations, groups did not differ in the magnitude of the pain interference effect and 
distraction efficacy. Although the overall performance of FM patients was slowed, the interference 
effect of low and moderately intense pain stimuli did not differ from the interference effect in 
healthy controls. This finding challenges the idea that painful stimuli more easily demand attention 
in FM patients than in healthy people. Instead, our results suggest that FM patients and healthy 
volunteers may have similar difficulties performing a primary task when experiencing pain. We 
did observe a general slowing in task performance in FM patients compared to healthy participants. 
This is in line with previous research revealing slower reaction times in chronic pain patients than 
in healthy controls (e.g., [55]). There may be several reasons for this slowed performance. First, 
the slowed performance may reflect impaired mental processing speed (e.g., [20,30]). Second, it is 
possible that the slower reaction times can be attributed to motor slowing. Indeed, performing the 
visual detection task required also a motor response (button press). Slowed motor responses may 
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for example, be due to the use of medication (or medication history) or reduced general physical 
fitness levels [13]. Unfortunately, the current study does not enable us to draw firm conclusions 
about whether the slow response times were due to problems in mental processing or motor speed, 
or both. 
The current findings suggest that distraction is as effective in FM patients as it is in healthy 
people. This finding contradicts some earlier findings (for an overview [54]) indicating that 
distraction is not effective or to a lesser extent in chronic pain patients compared to healthy 
controls. A number of reasons may explain this discrepancy. First, in contrast to most distraction 
studies in chronic pain patients (e.g., [22]), the experimental pain stimulus was of a short duration 
and of low to moderate intensity. It may well be that FM patients are able to increase their effort in 
a distraction task for a short timespan when pain is not too intense (See also [54]). Second, our 
control condition did not instruct participants to cope with pain as usual, often the case in previous 
distraction research in chronic pain patients, allowing for large variability in used strategies 
([21,22], but see also [45] for an exception). Instead participants were instructed to focus their 
attention on the pain stimuli (i.e., perform a somatosensory detection task). The fact that the 
difference in control condition could explain these diverging findings is in line with sub-analyses 
of a recent meta-analysis [54]. Results of this meta-analysis showed that, although distraction 
shows to be ineffective when compared with a no-instruction control condition, it does result in a 
pain reduction when being compared with a condition in which attention is focused on pain. A 
potential avenue for research is then to investigate to what extent patients with FM spontaneously 
make use of distraction strategies, and the possible reasons for not doing so. All in all, this finding 
points at the importance of well thought control conditions in distraction research. Third, it should 
be noted that although all participants experienced the pain stimuli as moderately painful, the 
stimulus intensity was substantially lower in FM patients compared to their healthy counterparts. 
This finding is in line with the central sensitisation hypothesis, which suggests that the 
responsiveness of central neurons to input from unimodal and polymodal receptors is augmented in 
FM patients, and results in generalized or widespread hypersensitivity [34,38]. The procedure 
followed in the current study, to determine individual pain thresholds, differs from most previous 
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distraction studies in chronic pain patients, in that they mostly used a fixed stimulus intensity for 
all participants (e.g., [21]). It may thus be that in current study distraction was equally effective in 
FM patients and healthy controls, because during the calibration phase we identified in each 
individual the intensity that was experienced as moderately painful. Therefore, at the start of the 
study, the self-reported intensity of the stimulus was not different between the FM and healthy 
controls. This approach was deliberate. When using a stimulus of fixed intensity (e.g., [21,22]), 
experienced pain may be higher in patients with FM than in healthy controls because of differences 
in low level processes involved in peripheral or central sensitisation. During the calibration phase, 
we instructed participants to pay close attention to the stimulus. That way, we reasoned that 
attention to pain was kept constant, and potential differences in the way participants habitually pay 
attention to pain were ruled out [1]. Future work should further explore this assumption. Finally, 
we found that the magnitude of task interference by pain is not related to distraction efficacy. This 
finding suggests that distraction efficacy is not just the counterpart of task interference by pain 
[50]. Distraction efficacy is based on self-report of pain and may be more prone to expectations of 
people and/or reporting or reflection biases. This may also explain why only distraction efficacy, 
and not task interference, was related to self-report measures of pain experience, catastrophizing, 
anxiety and levels of fatigue in FM patients.  
In addition to these theoretical implications, the current findings also have clinical 
implications. On the one hand, our results indicate that under specific conditions distraction may 
be useful in FM patients. That is, when pain is not intense and of short duration. It should be noted 
that our cognitive distraction task only resulted in a small reduction in self-reported pain. As such, 
the use of distraction strategies should be well-considered. On the other hand, our results also show 
that distraction may be less effective for FM patients who experience more intense chronic pain, 
catastrophize about their pain, are more anxious or more fatigued.  
This study has some limitations. First, the current study was performed in the lab using 
experimental pain stimuli. Although the use of experimental pain stimuli increases experimental 
control, it may be difficult to generalize findings to the everyday life of FM patients. Second, we 
opted to tailor the intensity of the experimental pain stimulus to an experience of moderate pain. 
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This resulted in the presentation of pain stimuli, which differed in their (objective) intensity.   
Other studies have most often used a fixed intensity procedure. Our results may differ from these 
studies because of this dissimilarity. Third, we did not assess whether the tactile stimulus was 
perceived as painful by the patients with FM. This is, however, unlikely as no patient mentioned 
that the tactile stimulus was perceived as painful and unpleasantness ratings of the tactile stimulus 
were low. There was also no difference in the unpleasantness ratings between FM patients and 
healthy participants. Fourth, the difference, between low intensity and moderate intensity pain 
stimuli was relatively small. This may have reduced the chances to find an impact upon distraction 
efficacy. Future research may opt to increase the difference between the intensity levels of pain 
stimuli.  
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Figure Captions 
Figure 1: Schematic illustration of the experimental set-up. 
Figure 2. Task interference effect per Group (FM patients vs control group) 
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Tables 
 
 
Healthy controls 
(n=49) 
FM patients 
(n=49) 
Group difference 
statistics 
Sex (females/males) 40/ 9 41/8 χ²(1) = 0.07, ns 
Age 45.39 (12.07) 45.20 (9.35) t(90.34) = .08, ns 
Education level (primary/ 
lower secondary/ higher 
secondary/ higher education 
2/ 2/ 19/ 26 2/ 7/ 21/ 19 χ²(3) = 3.97, ns 
Pain intensity (test moment) 2.10 (4.59) 44.08 (21.06) t(52.56) = 13.64, p < .001
PCS 9.88 (9.76) 21.90 (10.77) t(96) = 5.79, p < .001 
DASS-A 2.84 (3.48) 11.41 (7.42) t(68.21) = 7.32, p < .001 
DASS-D 5.61 (6.25) 13.41 (10.72) t(77.27) = 4.40, p < .001 
DASS-S 7.76 (7.24) 15.55 (7.81) t(96) = 5.12, p < .001 
BVS 14.19 (6.81) 18.59 (6.71) t(96) = 3.22, p < .01 
Table 1. Descriptive statistics per group (FM patients and control group). 
 
  Group Dis. eff. 
DASS- 
A 
DASS-
D 
DASS-
S 
MPI- 
ps PCS PDI BVS State PI
State 
fatigue
Task 
interference 
r .06 .08 .02 -.03 -.09 -.01 -.19 -.01 -.11 -.12 
df 95 95 95 95 47 95 47 95 95 95 
Distraction 
effect 
r - -.18t -.10 -.01 -.26t -.18t -.19 -.10 -.14 -.25* 
df - 95 95 95 47 95 47 95 95 95 
Table 2. Partial correlations controlled for Group (FM patients vs control group). For the MPI and PDI 
which were only assessed in the FM patient sample Pearson correlations are reported.  
 
